International

Master in Sustainable

Drug Discovery

Applications are open, how to apply can be found here.


Master in short

2 years

The S-DISCO programme is a 2-year full-time Master programme.

4 universities

The programme is organized by 4 European universities, i.e. Ghent University, Medical University of Gdańsk, University of Lille and the University of Groningen.

Master thesis

Students will perform a master thesis in one of the partner institutions or with one of the numerous associated partners (incl. industry, competent authorities and research institutions).

Master degree

Successful students will obtain a common master of science degree of the partner universities.

Target students

Candidates must hold a higher education diploma (180 ECTS or higher) in Chemical, Biological, (Bio-)Engineering, Pharmaceutical or Medical sciences.

Get involved


S-DISCO Programme

Learn about the S-DISCO programme and how to apply.

Our partners

The S-DISCO master degree has been built through close collaboration between the consortium and industrial players in the field in order to train high-level graduates with inter-and trans-disciplinary skills in the different fields of drug discovery, with a focus on sustainability. The partners will actively participate in the S-DISCO programme by i.a. teaching, holding seminars and providing internships to master thesis students. Discover our partners

News


The Young MedChem Forum (YMCF) of the Société de Chimie Thérapeutique (SCT) is organizing its second AskMeAnything session on September 22 from 6 p.m. to 7:30 p.m. for doctoral and post-doctoral students in medicinal and organic chemistry. Registration before September 20 https://forms.gle/yTM8nWExNxwPiPqe7 Follow the YMCF on LinkedIn and Twitter.
📣 APPLICATIONS ARE OPEN Applications for the S-DISCO programme (starting September 2023) are now open! The application deadline for scholarship and self-funded students is 31 January 2023, but early submissions are encouraged.
The WHO published an interesting position paper to realize the 2022-2031 neurological disorder action plan. It provides a conceptual framework how brain health can be optimized throughout life, and states i.a. that access to high-quality, safe and affordable neurological essential medicines are essential for optimizing brain health as they can reduce mortality and morbidity and […]

“Finding adequate treatments for unmet disease conditions, for everyone, everywhere, at a fair price, while respecting the environment and ecosystems is an enormous challenge, and one that we must be better prepared for.”

Bart De Spiegeleer, Ghent University

Scroll to Top